CHANDIGARH:
Pharmaceutical company Aventis Pharma Limited on Friday launched a new prefilled
disposable insulin pen diabetic patients and aims at increasing its market share
to 9 per cent with this launch.
"SoloSTAR, a disposable
insulin pen is to be used for the treatment of hyperglycemia in people with type
1 or type 2 diabetes and is now available in Chandigarh, Punjab, Haryana and
Himachal Pradesh," Aventis Pharma Limited, Senior Director, Susheel Umesh said
here on Friday.
" SoloSTARis
the result of over four years of intensive research and development. This pen
has been designed based on inputs from diabetic patients, their nurses and
doctors. Thus we are confident that this will cater to the needs of the
patients", he added.
It is an
easy-to-use insulin pen brings greater flexibility to patients and an
opportunity for earlier initiation of insulin therapy which may contribute to
better glycaemic control. This pen is designed in a very convenient manner
to enable patients carry it easily,
especially while travelling", added he said.
Currently, the market for
insulin stood at Rs. 460 crore and it is growing at a rate of 80 per cent. "We
will like to improve our market share to 9 per cent from 7 per cent at
present.